Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization

Author： Gleeson Matthew Paul   Montanari Dino  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.11, 2012-11, pp. : 1435-1446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In silico ADMET tools: the dawn of a new generation?

By Clark David E  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1423-1429

Informa Healthcare

Access to resources Recommend Favorite

In silico screening strategies for novel inhibitors of parasitic diseases

By Ferreira Rafaela S   Guido Rafael VC   Andricopulo Adriano D   Oliva Glaucius  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite

In silico analysis of antifungal peptides

By Soltani Saeed   Keymanesh Keykhosrow   Sardari Soroush  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite

Target validation in silico: does the virtual patient cure the pharma pipeline?

By Alkema Wynand   Rullmann Ton   van Elsas Andrea  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 635-638

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite